PARKE DAVIS FDA Approval ANDA 062030

ANDA 062030

PARKE DAVIS

FDA Drug Application

Application #062030

Application Sponsors

ANDA 062030PARKE DAVIS

Marketing Status

Discontinued001
Discontinued002

Application Products

001FOR SUSPENSION;ORALEQ 125MG BASE/5ML0AMCILLAMPICILLIN/AMPICILLIN TRIHYDRATE
002FOR SUSPENSION;ORALEQ 250MG BASE/5ML0AMCILLAMPICILLIN/AMPICILLIN TRIHYDRATE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62030
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.